| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.10M | 11.45M | 12.37M | 11.17M | 10.62M | 8.39M |
| Gross Profit | 8.53M | 7.98M | 8.24M | 8.35M | 8.13M | 6.43M |
| EBITDA | 174.00K | 237.00K | 3.58M | 2.90M | 2.94M | 2.67M |
| Net Income | -1.14M | -1.31M | 1.53M | 1.18M | 1.47M | 1.29M |
Balance Sheet | ||||||
| Total Assets | 10.19M | 11.55M | 12.97M | 11.68M | 11.65M | 10.31M |
| Cash, Cash Equivalents and Short-Term Investments | 608.00K | 840.00K | 796.00K | 728.00K | 1.64M | 826.00K |
| Total Debt | 4.21M | 4.81M | 5.67M | 6.71M | 7.77M | 9.71M |
| Total Liabilities | 10.31M | 12.04M | 12.12M | 12.42M | 13.60M | 13.77M |
| Stockholders Equity | -130.00K | -494.00K | 853.00K | -747.00K | -1.95M | -3.47M |
Cash Flow | ||||||
| Free Cash Flow | 3.33M | 3.43M | 1.21M | 58.00K | 1.81M | 656.00K |
| Operating Cash Flow | 3.46M | 3.60M | 3.38M | 2.06M | 3.41M | 2.06M |
| Investing Cash Flow | -1.81M | -2.40M | -2.17M | -2.00M | -1.60M | -1.41M |
| Financing Cash Flow | -1.10M | -1.07M | -1.10M | -1.00M | -1.00M | -1.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £48.27M | 10.81 | 17.36% | 4.20% | 5.46% | 12.34% | |
75 Outperform | £442.08M | 27.44 | 26.93% | ― | 121.45% | 345.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | £22.13M | 6.08 | 364.42% | ― | -0.46% | -171.65% | |
58 Neutral | £42.24M | -17.38 | 2.30% | 2.02% | 20.83% | ― | |
49 Neutral | £26.65M | -2.04 | -35.93% | ― | -13.95% | 4.29% | |
44 Neutral | £19.37M | -6.07 | ― | ― | ― | ― |